Skip to content
Application 206872
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ENTECAVIR | ENTECAVIR | TABLET;ORAL | 0.5MG | No | No |
| 002 | ENTECAVIR | ENTECAVIR | TABLET;ORAL | 1MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 16714-717 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-717 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-717 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-717 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-718 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-718 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-718 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 16714-718 | ENTECAVIR | ENTECAVIR | NorthStar RxLLC | ANDA | Current |
| 69097-425 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-425 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-425 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-425 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-425 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-426 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-426 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-426 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-426 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |
| 69097-426 | ENTECAVIR | ENTECAVIR | Cipla USA Inc. | ANDA | Current |